Central African Republic vs Lesotho: Adults (ages 15-49) newly infected with HIV
Central African Republic
2,800
in 2024
Lesotho
2,700
in 2024
Central African Republic rank
41st
Lesotho rank
43rd
Adults (ages 15-49) newly infected with HIV over time
- Central African Republic
- Lesotho
How they compare
Central African Republic currently reports 2,800 against 2,700 in Lesotho, a difference of 100.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was Central African Republic ahead.
Central African Republic ranks 41st and Lesotho ranks 43rd of 140 countries.
Lesotho has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Central African Republic | Lesotho | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 14,300 | 20,800 | 6,500 | Lesotho |
| 2000s | 9,080 | 18,400 | 9,320 | Lesotho |
| 2010s | 5,650 | 11,160 | 5,510 | Lesotho |
| 2020s | 3,200 | 3,640 | 440 | Lesotho |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher adults (ages 15-49) newly infected with hiv, Central African Republic or Lesotho?
- Central African Republic, at 2,800 against 2,700 in Lesotho as of 2024.
- What is the difference in adults (ages 15-49) newly infected with hiv between Central African Republic and Lesotho?
- 100, with Central African Republic ahead.
- How many years of comparable data are there for Central African Republic and Lesotho?
- 35 years are reported by both, from 1990 to 2024.
- How do Central African Republic and Lesotho rank globally for adults (ages 15-49) newly infected with hiv?
- Central African Republic ranks 41st and Lesotho ranks 43rd of 140 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Adults (ages 15-49) newly infected with HIV. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of adults (ages 15-49) newly infected with HIV.